Skip to main content

Table 3 In-hospital and mid-term clinical outcome

From: Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial

Clinical outcome

N (%)

M-ALA

0 (0)

CA-AKI

9 (6.1)

All-cause death

2 (1.4)

In-hospital death

0 (0)

Cardiac death

0 (0)

MI

1 (0.7)

Definite or probable ST

1 (0.7)

Any revascularization

5 (3.5)

Stroke

2 (1.5)

Any rehospitalization

14 (9.5)

Any bleeding

5 (3.4)

  1. CA-AKI contrast-associated kidney injury, M-ALA metformin-associated lactic acidosis, MI myocardial infarction, ST stent thrombosis
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840